Quimi Daphne 4
4 · Century Therapeutics, Inc. · Filed Sep 16, 2024
Insider Transaction Report
Form 4
Quimi Daphne
Director
Transactions
- Purchase
Common Stock
2024-09-12$1.53/sh+5,000$7,657→ 5,000 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.525 to $1.54. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.